The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Low-Dose Amiodarone for Maintenance of Sinus Rhythm After Cardioversion of Atrial Fibrillation or Flutter
Abstract
OBJECTIVE: To study efficacy and safety of low-dose amiodarone for maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation or flutter. DESIGN: Nonrandomized trial; mean duration of follow-up, 20.7 months. SETTING: Referral center; institutional practice; both hospitalized and ambulatory care. PATIENTS: Eighty-nine consecutive patients having chronic atrial fibrillation or flutter and eligible for cardioversion. Patients had failed previous treatment aimed at maintaining sinus rhythm. During follow-up one patient was withdrawn because of side effects; all patients were available for follow-up. INTERVENTION: Before cardioversion, patients received 600 mg of amiodarone daily during a 4-week loading period. After conversion, the daily maintenance dose was 204 +/- 66 mg (mean +/- SD). MAIN OUTCOME MEASURES: Arrhythmia recurrence and adverse effects causing drug discontinuation. RESULTS: During loading, 15 patients (16%) converted, and after electrical cardioconversion, 90% of all patients had sinus rhythm. Actuarially, 53% of these patients were still in sinus rhythm after 3 years. In patients with compromised left ventricular function, 93% maintained sinus rhythm after 6 months. One patient died due to congestive heart failure. Intolerable side effects occurred in one patient. No proarrhythmia was observed. Logistic regression analysis revealed that amiodarone was ineffective in patients with mitral stenosis or chronic arrhythmia. CONCLUSIONS: Low-dose amiodarone is effective for maintaining sinus rhythm in patients with difficult to treat chronic atrial fibrillation or flutter and is associated with a low incidence of serious side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coplen, S. E., Antman, E. M., Berlin, J. A., Hewitt, P., & Chalmers, T. C. (1990) · Circulation · doi:10.1161/01.cir.82.4.1106 · Cited by 945
Clinical efficacy of amiodarone as an antiarrhythmic agent
Rosenbaum, M. B., Chiale, P. A., Halpern, M. S., Nau, G. J., Przybylski, J., Levi, R. J., Lázzari, J. O., & Elizari, M. V. (1976) · The American Journal of Cardiology · doi:10.1016/0002-9149(76)90807-9 · Cited by 566
Crijns, H. J., Van Gelder, I. C., Van Gilst, W. H., Hillege, H., Gosselink, A. M., & Lie, K. I. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90828-9 · Cited by 275
Self-citationAmiodarone: Historical development and pharmacologic profile
Singh, B. N. (1983) · American Heart Journal · doi:10.1016/0002-8703(83)90002-9 · Cited by 243
Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.
Haffajee, C. I., Love, J. C., Canada, A. T., Lesko, L. J., Asdourian, G., & Alpert, J. S. (1983) · Circulation · doi:10.1161/01.cir.67.6.1347 · Cited by 240
Amiodarone for refractory atrial fibrillation
Gold, R. L., Haffajee, C. I., Charos, G., Sloan, K., Baker, S., & Alpert, J. S. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90964-1 · Cited by 218
Van Gelder, I. C., Crijns, H. J. G. M., Van Gilst, W. H., Van Wijk, L. M., Hamer, H. P. M., & Lie, K. I. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90574-2 · Cited by 187
Amiodarone in Refractory Life-Threatening Ventricular Arrhythmias
Nademanee, K., Singh, B. N., HENDRICKSON, J., INTARACHOT, V., LOPEZ, B., FELD, G., Cannom, D. S., & Weiss, J. N. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-5-577 · Cited by 183
Horowitz, L. N., Spielman, S. R., Greenspan, A. M., Mintz, G. S., Morganroth, J., Brown, R., Brady, P. M., & Kay, H. R. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80232-1 · Cited by 159
Brodsky, M. A., Allen, B. J., Walker, C. J., Casey, T. P., Luckett, C. R., & Henry, W. L. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90307-9 · Cited by 154
Cited by
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 9,971
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary
Fuster, V., Rydén, L. E., Asinger, R. W., Cannom, D. S., Crijns, H. J., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01587-x · Cited by 1,348
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.009 · Cited by 1,158
Amiodarone to Prevent Recurrence of Atrial Fibrillation
Roy, D., Talajic, M., Dorian, P., Connolly, S., Eisenberg, M. J., Green, M., Kus, T., Lambert, J., Dubuc, M., Gagné, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421302 · Cited by 1,143
The Management of Hypertrophic Cardiomyopathy
Spirito, P., Seidman, C. E., McKenna, W. J., & Maron, B. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703133361107 · Cited by 1,007
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Le Huezey, J.-Y., Lowe, J. E., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.013 · Cited by 924
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Le Huezey, J.-Y., Lowe, J. E., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318214876d · Cited by 859
Writing Committee Members, Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., et al. (2006) · Europace · doi:10.1093/europace/eul097 · Cited by 667
Authors/Task Force Members, Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl176 · Cited by 644
Prystowsky, E. N., Benson, D. W., Fuster, V., Hart, R. G., Kay, G. N., Myerburg, R. J., Naccarelli, G. V., & Wyse, D. G. (1996) · Circulation · doi:10.1161/01.cir.93.6.1262 · Cited by 635
Committee Members, Fuster, V., Rydén, L. E., Asinger, R. W., Cannom, D. S., Crijns, H. J., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., et al. (2001) · Circulation · doi:10.1161/circ.104.17.2118 · Cited by 604
Preoperative Amiodarone as Prophylaxis against Atrial Fibrillation after Heart Surgery
Daoud, E. G., Strickberger, S. A., Man, K. C., Goyal, R., Deeb, G. M., Bolling, S. F., Pagani, F. D., Bitar, C., Meissner, M. D., & Morady, F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712183372501 · Cited by 529
Deedwania, P. C., Singh, B. N., Ellenbogen, K., Fisher, S., Fletcher, R., & Singh, S. N. (1998) · Circulation · doi:10.1161/01.cir.98.23.2574 · Cited by 506
Pedersen, O. D., Bagger, H., Keller, N., Marchant, B., Køber, L., & Torp-Pedersen, C. (2001) · Circulation · doi:10.1161/01.cir.104.3.292 · Cited by 496
(2001) · European Heart Journal · doi:10.1053/euhj.2001.2983 · Cited by 494
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.018 · Cited by 467
Prescribing Amiodarone: An Evidence-Based Review of Clinical Indications
Vassallo, P., & Trohman, R. G. (2007) · JAMA · doi:10.1001/jama.298.11.1312 · Cited by 441
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
Lafuente-Lafuente, C., Valembois, L., Bergmann, J.-F., & Belmin, J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005049.pub4 · Cited by 423
Adverse Effects of Low Dose Amiodarone: A Meta-Analysis
Vorperian, V. R., Havighurst, T. C., Miller, S., & January, C. T. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00220-9 · Cited by 419
Jabaudon, D., Sztajzel, J., Sievert, K., Landis, T., & Sztajzel, R. (2004) · Stroke · doi:10.1161/01.str.0000131269.69502.d9 · Cited by 414
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177031 · Cited by 345
Atrial fibrillation: current knowledge and recommendations for management*1
LEVY, S. (1998) · European Heart Journal · doi:10.1053/euhj.1998.1050 · Cited by 323
Franz, M. R., Karasik, P. L., Li, C., Moubarak, J., & Chavez, M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00385-9 · Cited by 301
(1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015339 · Cited by 296
Da Costa, A., Thévenin, J., Roche, F., Romeyer-Bouchard, C., Abdellaoui, L., Messier, M., Denis, L., Faure, E., Gonthier, R., Kruszynski, G., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.638395 · Cited by 140
Management of Atrial Fibrillation in Adults: Prevention of Thromboembolism and Symptomatic Treatment
Blackshear, J. L., Kopecky, S. L., Litin, S. C., Safford, R. E., & Hammill, S. C. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.2.150 · Cited by 67
Alterations in atrial electrophysiology associated with chronic atrial fibrillation in man
Kamalvand, K. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1404 · Cited by 47
“Only 30‐60% of patients remain in sinus rhythm a year after successful cardioversion despite the use of antiarrhythmic drugs[6, 7 ].”
BackgroundLong-term outcome of electrical cardioversion in patients with chronic atrial flutter
Crijns, H. J., Van Gelder, I. C., Tieleman, R. G., Brügemann, J., De Kam, P. J., Gosselink, A. T., Bink-Boelkens, M. T., & Lie, K. I. (1997) · Heart · doi:10.1136/hrt.77.1.56 · Cited by 46
Self-citationJohnson, S. G., Canty, K., Billups, S., & Schimmer, J. (2010) · Journal of Pharmacy Practice · doi:10.1177/0897190009358770 · Cited by 14
Metadata
- Authors
- Gosselink, A. T. M.
- Venue
- JAMA: The Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1992-06-24
- Volume
- 267
- Issue
- 24
- Pages
- 3289
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2151184079
- Cited by
- 281
- References
- 28
- FWCI
- 8.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.